Diphenhydramine, the active ingredient in Benadryl and many over-the-counter sleep aids, is widely considered safe for the liver at recommended doses, and the vast majority of people who take it will never experience liver problems from it. That said, the drug is heavily processed by the liver, and at least one documented case links high-dose chronic use to serious liver injury without any other medication involved. The real-world risk profile is more nuanced than a simple yes or no, depending on how much you take, how long you take it, what else you’re taking alongside it, and whether your liver is already compromised.
How the Liver Handles Diphenhydramine
Understanding why the liver is even part of this conversation starts with how your body breaks diphenhydramine down. When you swallow a tablet, roughly 50 to 60 percent of the dose is metabolized by the liver before it ever reaches your bloodstream, a process called first-pass metabolism.1PubMed Central. Diphenhydramine as a Cause of Drug-Induced Liver Injury That means the liver does a lot of heavy lifting with this drug. Nearly all of the available diphenhydramine is metabolized by the liver within 24 to 48 hours.
The primary enzyme responsible for breaking down diphenhydramine is CYP2D6, which showed the highest activity of any enzyme tested in laboratory studies using human liver tissue. Several backup enzymes, including CYP1A2, CYP2C9, and CYP2C19, also contribute, though at lower efficiency.2PubMed. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation This matters because it means the liver isn’t relying on a single pathway. If one enzyme is busy or underperforming, others can pick up some of the slack, which is part of why normal doses are generally well tolerated.
The Case That Changed the Conversation
For a long time, diphenhydramine was assumed to pose minimal or no direct risk to liver cells. There were reports of liver damage when people took diphenhydramine together with acetaminophen, but no one had convincingly shown that diphenhydramine alone could injure the liver. That changed with a published case report describing a patient who developed severe drug-induced liver injury from diphenhydramine without any other hepatotoxic medication in the picture.1PubMed Central. Diphenhydramine as a Cause of Drug-Induced Liver Injury
The patient had been taking at least 400 mg of diphenhydramine per day for more than four months. For context, the standard adult dose for allergies or sleep is 25 to 50 mg, so this person was consistently taking eight to sixteen times the normal dose. On admission, liver enzyme levels were extremely elevated: the AST was over 10,000 IU/L and ALT was nearly 2,500 IU/L, both numbers that signal massive liver cell damage. By the second day, those numbers had climbed even higher, with AST exceeding 20,000 IU/L and blood clotting function deteriorating as well.3PubMed Central. Diphenhydramine as a Cause of Drug-Induced Liver Injury – Section: Case
Doctors ran an exhaustive workup. Viral hepatitis A through E was ruled out. Autoimmune liver disease was negative. Metabolic conditions like Wilson’s disease were excluded. A liver biopsy was consistent with drug-induced liver injury, and diphenhydramine was identified as the likely cause. The case authors noted that prior to this report, there were no documented cases in the medical literature of diphenhydramine alone causing this kind of injury. The finding suggests that while the drug is safe for most people at recommended doses, chronic high-dose use can overwhelm the liver’s capacity to handle it.
Why High Doses and Chronic Use Raise the Risk
The reason chronic overuse is particularly concerning comes back to first-pass metabolism. When the liver processes 50 to 60 percent of every dose you swallow, doubling or quadrupling that dose doesn’t just double the amount of drug in your blood. It also doubles the metabolic workload on your liver cells. The enzymes responsible for breaking down diphenhydramine can become saturated, meaning they’re working at full capacity and can’t keep up. When that happens, either the unmetabolized drug accumulates or toxic intermediate metabolites build up, both of which can damage liver cells.
This problem is compounded when overuse becomes chronic. Taking a large dose once gives the liver 24 to 48 hours to clear it. Taking a large dose every day for months means the liver never gets a real break. Over time, repeated insults to liver cells can trigger inflammation, cell death, and the cascade that shows up as sky-high liver enzymes on a blood test. The case report patient’s pattern of use, at least 400 mg daily for over four months, is exactly the kind of scenario where this cumulative damage can occur.
It’s worth noting that diphenhydramine misuse and overuse are not uncommon. Some people take it habitually as a sleep aid, gradually increasing their dose as tolerance builds. Others misuse it for its sedative or, at very high doses, its hallucinogenic effects. In these populations, the liver faces a workload it was never designed to handle on a nightly basis.
The Acetaminophen Complication
Many over-the-counter products combine diphenhydramine with acetaminophen (Tylenol PM being the most recognizable example). This combination is relevant because acetaminophen is one of the most common causes of drug-induced liver damage in the developed world, and people don’t always realize their sleep aid contains it. When liver injuries are attributed to these combination products, it can be hard to tease apart which ingredient did the damage.
A study examining overdose outcomes with acetaminophen alone versus combination products found that a substantial proportion of cases involved over-the-counter combinations, including acetaminophen/diphenhydramine preparations.4PubMed Central. Risk Factors, Clinical Presentation, and Outcomes in Overdose With Acetaminophen Alone or With Combination Products In a separate analysis of fatalities involving acetaminophen combination products reported to U.S. poison centers, acetaminophen was identified as the likely cause of death in about 61 percent of cases, while other ingredients accounted for roughly 30 percent, and the remaining cases couldn’t be clearly attributed.5PubMed. Fatalities involving acetaminophen combination products reported to United States poison centers
The practical takeaway here is that if you’re taking a product like Tylenol PM, the liver risk is primarily driven by the acetaminophen component, not the diphenhydramine. But both ingredients are processed by the liver, and taking both at elevated doses puts extra strain on the organ. People who already take acetaminophen for pain and then add a diphenhydramine/acetaminophen sleep aid at night can easily exceed the maximum safe daily dose of acetaminophen (typically 3,000 to 4,000 mg for healthy adults) without realizing it. Always check labels for acetaminophen content in any combination product.
If You Already Have Liver Disease
For people with existing liver problems, diphenhydramine behaves differently. A study comparing people with alcohol-related cirrhosis to healthy individuals found that the elimination half-life of diphenhydramine roughly doubled, going from about 9 hours in healthy people to around 15 hours in those with cirrhosis.6PubMed. Diphenhydramine disposition in chronic liver disease 7PubMed. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines) The half-life also correlated with disease severity: the worse the liver function, the longer the drug stuck around.
What this means in practice is that a standard dose of diphenhydramine lingers in a cirrhotic patient’s body for much longer than intended. If someone with liver disease takes it nightly as a sleep aid, each new dose arrives before the previous one has been fully cleared, leading to accumulation. The result can be excessive sedation, confusion, and other anticholinergic side effects like dry mouth, urinary retention, and rapid heart rate. Whether this accumulation also raises the risk of further liver injury specifically is less clear from available evidence, but the prolonged exposure alone is reason enough for caution.
If you have diagnosed liver disease of any kind, including fatty liver disease, hepatitis, or cirrhosis, talk to your doctor before using diphenhydramine regularly. In many cases, a lower dose or an alternative antihistamine that isn’t as heavily liver-metabolized may be a better choice.
How Genetic Differences Affect Metabolism
Not everyone’s liver processes diphenhydramine at the same speed. The CYP2D6 enzyme, which does most of the work, varies considerably between individuals based on genetics. Some people carry extra copies of the CYP2D6 gene and are classified as ultrarapid metabolizers, meaning they chew through CYP2D6 substrates much faster than average. A case series described three ultrarapid metabolizers who experienced paradoxical excitation, essentially the opposite of drowsiness, when they took diphenhydramine.8PubMed. Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports The authors suggested that in these individuals, diphenhydramine may be converted unusually fast into a metabolite that causes stimulation rather than sedation.
On the other end of the spectrum, poor metabolizers carry reduced-function or nonfunctional copies of CYP2D6 and break the drug down much more slowly. For these people, a standard dose could produce more intense and longer-lasting effects, and the liver spends more time processing each dose. This genetic variability is one reason why some people feel barely affected by a single Benadryl while others are knocked out for hours. It also theoretically means that poor metabolizers who take diphenhydramine chronically may face somewhat higher liver exposure to the drug over time, though no studies have directly tested whether this translates into a higher liver injury risk.
Roughly 6 to 10 percent of people of European descent are CYP2D6 poor metabolizers, while ultrarapid metabolizers are more common in certain North African and Middle Eastern populations. Most people fall somewhere in the middle and process diphenhydramine within the expected timeframe. Genetic testing for CYP2D6 status exists but is rarely done for over-the-counter antihistamine use.
Drug Interactions That Increase Liver Workload
Diphenhydramine’s relationship with CYP2D6 goes both ways. It’s not only broken down by this enzyme; research has found that it also mildly inhibits CYP2D6 activity, essentially acting as both a passenger and a speed bump on the same metabolic highway.8PubMed. Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports One study found that a single dose of diphenhydramine did not produce a statistically significant change in CYP2D6 activity in healthy volunteers,9PubMed. Effects of terfenadine and diphenhydramine on the CYP2D6 activity in healthy volunteers suggesting the inhibition is modest at normal doses. But the story may be different at higher or repeated doses, where the cumulative inhibitory effect could slow down the metabolism of other drugs that rely on CYP2D6.
A number of commonly used medications are processed by CYP2D6, including certain antidepressants, beta-blockers, and codeine. If you’re taking any of these alongside diphenhydramine, the competition for that enzyme could slow the breakdown of both drugs, raising blood levels of each. For the liver, this means more metabolic traffic and potentially more exposure to reactive intermediates. Again, this is unlikely to matter much from a single dose, but chronic nightly use of diphenhydramine alongside other CYP2D6 substrates could compound the effect.
What About Newer Antihistamines
Diphenhydramine is a first-generation antihistamine, meaning it crosses into the brain and causes drowsiness, which is exactly why it ended up in sleep aids. Newer, second-generation antihistamines like cetirizine (Zyrtec) and loratadine (Claritin) were specifically designed to stay out of the brain and reduce sedation. They also tend to undergo less extensive liver metabolism. Cetirizine, for instance, is largely excreted unchanged by the kidneys, which means the liver isn’t doing nearly as much processing work compared to diphenhydramine.
For people who need an antihistamine for allergies and are concerned about liver load, whether because of existing liver disease, chronic medication use, or simply a preference for caution, a second-generation option is generally a better bet. These drugs are not entirely free of liver processing, and rare cases of liver injury have been reported with almost every drug that exists, but the metabolic burden on the liver is meaningfully lower. The one caveat is that second-generation antihistamines are less effective as sleep aids, which is the reason many people reach for diphenhydramine in the first place.
Chronic Use as a Sleep Aid
One of the most common real-world scenarios where diphenhydramine liver concerns arise is nightly use for insomnia. Millions of people take diphenhydramine-based sleep aids routinely, sometimes for years. Tolerance develops relatively quickly, which means people start taking more to get the same effect. A person who began with one 25 mg tablet may eventually be taking two or three, and some report taking even more than that.
Beyond the liver question, chronic diphenhydramine use carries well-established concerns about cognitive function, particularly in older adults. Anticholinergic drugs as a class have been linked to increased risk of dementia with long-term use, and diphenhydramine is one of the more potent anticholinergics in everyday consumer products. The liver risk is real but comparatively rare at standard doses; the brain-related risks from chronic use arguably deserve more attention than they get.
If you’ve been using diphenhydramine nightly for more than a couple of weeks, it’s worth having a conversation with a doctor about alternatives. Cognitive behavioral therapy for insomnia is considered the first-line treatment and has no organ toxicity. Melatonin, while not a cure-all, works through a completely different mechanism and places virtually no metabolic demand on the liver. Even if you’ve found that diphenhydramine is the only thing that helps you sleep, knowing the long-term profile helps you weigh the trade-offs honestly.
Signs of Liver Trouble to Watch For
If you do take diphenhydramine regularly, whether at recommended or elevated doses, it helps to know what early liver distress looks like. Symptoms often include:
- Fatigue: persistent tiredness that doesn’t improve with rest, beyond what you’d attribute to the drug’s sedative effects.
- Dark urine: urine that turns tea- or cola-colored can indicate bilirubin spilling over from a struggling liver.
- Yellowing skin or eyes: jaundice is one of the more recognizable signs that the liver is failing to clear bilirubin properly.
- Upper right abdominal pain: discomfort or tenderness below the right rib cage, where the liver sits.
- Nausea or loss of appetite: a general feeling of being unwell, particularly around food.
These symptoms aren’t specific to diphenhydramine-related liver injury; they can indicate liver problems from any cause. But if you notice any of them while taking diphenhydramine regularly, especially at doses above the label recommendation, stop taking it and see a healthcare provider. Liver enzyme tests are simple blood draws and can quickly reveal whether your liver is under stress. In the published case report, the patient’s enzyme levels were catastrophically high by the time they sought care, which underscores the value of catching things early rather than waiting for obvious symptoms.